Related Experiment Video
Updated: Jul 3, 2026
10:13
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor
Xiaojie Yao1, Charles Parnot, Xavier Deupi
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, Palo Alto, California 94305, USA.
Nature Chemical Biology
|June 27, 2006
Summary
Ligand binding to G protein-coupled receptors (GPCRs) like the beta2-adrenoceptor (beta2-AR) involves conformational changes. Disrupting the
Area of Science:
- Biochemistry and Molecular Pharmacology
- G protein-coupled receptor (GPCR) research
- Molecular mechanisms of signal transduction
Background:
- G protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
- Ligand binding to GPCRs can elicit diverse functional responses, even among structurally similar molecules.
- The 'ionic lock' is a proposed mechanism in rhodopsin-like GPCRs that stabilizes the inactive receptor conformation.
Purpose of the Study:
- To investigate the relationship between ligand efficacy and conformational changes in the human beta2-adrenoceptor (beta2-AR).
- To determine the role of the 'ionic lock' in the activation process of the beta2-AR by ligands with varying efficacies.
Main Methods:
- Utilized fluorescence spectroscopy to monitor ligand-induced conformational changes in the beta2-AR.
- Studied the effect of full agonists and partial agonists on the disruption of the 'ionic lock'.
Main Results:
- Most partial agonists were as effective as full agonists in disrupting the 'ionic lock' of the beta2-AR.
- Disruption of the 'ionic lock' was observed to be a necessary but not sufficient step for full receptor activation.
Conclusions:
- The 'ionic lock' is a critical molecular switch in GPCRs, essential for initiating the activation cascade.
- Full activation of the beta2-AR requires additional conformational events beyond the disruption of the 'ionic lock'.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...